title: How can valid informed consent be obtained from a psychotic patient for research into psychosis? Three perspectives.
authors.affiliation: Law Faculty, Monash University, Australia.
authors.forename: Ian
authors.initials: I
authors.lastname: Freckelton
authors.forename: Nicholas
authors.initials: N
authors.lastname: Keks
authors.forename: Vivienne
authors.initials: V
authors.lastname: Howe
authors.forename: Kelly
authors.initials: K
authors.lastname: Foister
authors.forename: Kym
authors.initials: K
authors.lastname: Jenkins
authors.forename: David
authors.initials: D
authors.lastname: Copolov
authors.forename: Danny
authors.initials: D
authors.lastname: Sullivan
mesh_terms: D016223:Advance Directives; D001315:Australia; D003071:Cognition; D030881:Disclosure / Q000592:standards; D032984:Ethics, Research; D006805:Human Experimentation / Q000941:ethics; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence / Q000523:psychology / Q000592:standards*; D016743:Mental Competency / Q000331:legislation & jurisprudence / Q000523:psychology / Q000592:standards*; D028642:Persons with Psychiatric Disorders; D010919:Placebos / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012107:Research Design; D035842:Research Subjects; D012559:Schizophrenia / Q000188:drug therapy; D028761:Withholding Treatment
chemical_list: D010919:Placebos; D011619:Psychotropic Drugs